Precigen (PGEN) Asset Utilization Ratio (2013 - 2026)

Precigen (PGEN) reported Asset Utilization Ratio of 0.19 for Q1 2026, up 496.96% year-over-year from 0.03 in Q1 2025, and up 420.9% quarter-over-quarter from 0.04 in Q4 2025.

Precigen (PGEN) Asset Utilization Ratio (2013 - 2026) Analysis & Trends

Precigen (PGEN) has 14 years of Asset Utilization Ratio data on file, last reported at 0.19 in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.19, up 496.96% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.19 (up 496.96% YoY), and the FY2025 annual result was 0.06, up 143.07% from the prior year.
  • Asset Utilization Ratio climbed to 0.19 in Q1 2026 per PGEN's latest filing, from 0.04 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.19 in Q1 2026 and troughed at 0.06 in Q3 2023.
  • A 5-year average of 0.02 and a median of 0.02 in 2024 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio plunged 57351.3% in 2023, then soared 496.96% in 2026.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2022, then soared by 211.63% to 0.02 in 2023, then surged by 41.48% to 0.03 in 2024, then soared by 32.25% to 0.04 in 2025, then soared by 420.9% to 0.19 in 2026.
  • Business Quant data shows PGEN's Asset Utilization Ratio at 0.19 in Q1 2026, 0.04 in Q4 2025, and 0.02 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 0.55
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 1,422.00
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 0.47
9 Abivax 94.37 Bn 94.37 Bn - -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn 0.19

Historic Data

Download Data
DateValue
Mar 31, 2026 0.19
Dec 31, 2025 0.04
Sep 30, 2025 0.02
Jun 30, 2025 0.03
Mar 31, 2025 0.03
Dec 31, 2024 0.03
Sep 30, 2024 0.04
Jun 30, 2024 0.02
Mar 31, 2024 0.02
Dec 31, 2023 0.02
Sep 30, 2023 -0.06
Jun 30, 2023 -0.05
Mar 31, 2023 -0.04
Dec 31, 2022 -0.02
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.01
Dec 31, 2021 0.06
Sep 30, 2021 0.13
Jun 30, 2021 0.18